Background Clostridium difficile is a leading cause of morbidity and mortality in several
countries. However, there are limited evidence characterizing its role as a global public …

Nosocomial infections are also known as hospital-acquired/associated infections. National
Healthcare Safety Network along with Centers for Disease Control for surveillance has …

Clostridium difficile infection (CDI) continues to affect patients in hospitals and communities
worldwide. The spectrum of clinical disease ranges from mild diarrhoea to toxic megacolon …

Clostridium difficile, an anaerobic toxigenic bacterium, causes a severe infectious colitis that
leads to significant morbidity and mortality worldwide. Both enhanced bacterial toxins and …

While Clostridium difficile infection (CDI) has come to prominence as major epidemics have
occurred in North America and Europe over the recent decade, awareness and surveillance …

Clostridium (reclassified as “Clostridioides”) difficile infection (CDI) is a healthcare-
associated infection and significant source of potentially preventable morbidity, recurrence …

Background Clostridium difficile infection (CDI) is the most common healthcare associated
infection and is highly prevalent in Europe and North America. Limited data is available on …

Clostridium difficile ribotype (RT) 017 is an important toxigenic C. difficile RT which, due to a
deletion in the repetitive region of the tcdA gene, only produces functional toxin B. Strains …

Toxigenic culture and cytotoxicity assays are standard tests for detecting C. difficile infection
(CDI). Others include immunochromatographic strips, a rapid diagnostic test that detects …

Abstract Introduction The prevalence of Clostridium difficile infection is rapidly increasing
worldwide, but prevalence is difficult to estimate in developing countries where awareness …